Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Production of monoclonal antibodies against a 19-kD recombinant Plasmodium vivax MSP1 for detection of P. vivax malaria in Turkey.

Ak M, Babaoğlu A, Dağci H, Türk M, Bayram S, Ertabaklar H, Ozcel MA, Uner A, Charoenvit Y, Kumar S, Hoffman SL.

Hybrid Hybridomics. 2004 Apr;23(2):133-6.

PMID:
15165487
3.

The Plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of P. vivax.

Cheng Y, Wang Y, Ito D, Kong DH, Ha KS, Chen JH, Lu F, Li J, Wang B, Takashima E, Sattabongkot J, Tsuboi T, Han ET.

Infect Immun. 2013 May;81(5):1585-95. doi: 10.1128/IAI.01117-12. Epub 2013 Mar 4.

4.

Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.

Fernandez-Becerra C, Sanz S, Brucet M, Stanisic DI, Alves FP, Camargo EP, Alonso PL, Mueller I, del Portillo HA.

Malar J. 2010 Jan 21;9:29. doi: 10.1186/1475-2875-9-29.

5.

Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.

Devi YS, Mukherjee P, Yazdani SS, Shakri AR, Mazumdar S, Pandey S, Chitnis CE, Chauhan VS.

Vaccine. 2007 Jul 9;25(28):5166-74. Epub 2007 May 21.

PMID:
17544179
6.

Plasmodium vivax: epitope mapping of monoclonal antibodies against the N-terminal region of the merozoite surface protein 1.

Levitus G, Mertens F, Kirchgatter K, Oliveira SG, del Portillo HA.

Behring Inst Mitt. 1997 Mar;(99):107-11.

PMID:
9303209
7.

Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1.

Soares IS, da Cunha MG, Silva MN, Souza JM, Del Portillo HA, Rodrigues MM.

Am J Trop Med Hyg. 1999 Mar;60(3):357-63.

PMID:
10466961
8.

Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax.

Barbedo MB, Ricci R, Jimenez MC, Cunha MG, Yazdani SS, Chitnis CE, Rodrigues MM, Soares IS.

Mem Inst Oswaldo Cruz. 2007 Jun;102(3):335-9.

9.

Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey.

Zeyrek FY, Babaoglu A, Demirel S, Erdogan DD, Ak M, Korkmaz M, Coban C.

Am J Trop Med Hyg. 2008 May;78(5):729-32.

PMID:
18458304
10.

IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.

Pitabut N, Panichakorn J, Mahakunkijcharoen Y, Hirunpetcharat C, Looareesuwan S, Khusmith S.

Southeast Asian J Trop Med Public Health. 2007 Jan;38(1):1-7.

PMID:
17539238
11.
12.
14.

Immunogenicity of a plasmid DNA vaccine encoding 42kDa fragment of Plasmodium vivax merozoite surface protein-1.

Sheikh IH, Kaushal DC, Chandra D, Kaushal NA.

Acta Trop. 2016 Oct;162:66-74. doi: 10.1016/j.actatropica.2016.06.013. Epub 2016 Jun 14.

PMID:
27311385
15.

Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.

Kaushal DC, Kaushal NA, Narula A, Kumar N, Puri SK, Dutta S, Lanar DE.

Indian J Biochem Biophys. 2007 Dec;44(6):429-36.

PMID:
18320841
16.

Measurement of naturally acquired humoral immune responses against the C-terminal region of the Plasmodium vivax MSP1 protein using protein arrays.

Chen JH, Wang Y, Ha KS, Lu F, Suh IB, Lim CS, Park JH, Takeo S, Tsuboi T, Han ET.

Parasitol Res. 2011 Nov;109(5):1259-66. doi: 10.1007/s00436-011-2370-z. Epub 2011 Apr 13.

PMID:
21487779
18.

A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies.

Soares IS, Barnwell JW, Ferreira MU, Gomes Da Cunha M, Laurino JP, Castilho BA, Rodrigues MM.

Mol Med. 1999 Jul;5(7):459-70.

19.

Limited polymorphism of the Plasmodium vivax merozoite surface protein 1 gene in isolates from Turkey.

Zeyrek FY, Tachibana S, Yuksel F, Doni N, Palacpac N, Arisue N, Horii T, Coban C, Tanabe K.

Am J Trop Med Hyg. 2010 Dec;83(6):1230-7. doi: 10.4269/ajtmh.2010.10-0353.

20.

Efficacy of the merozoite surface protein 1 of Plasmodium vivax as an antigen for ELISA to diagnose malaria.

Kim YM, Hwang HA, Yun WS, Kim SI, Lee KW, Park SK, Lee YJ, Kim TK, Wongsrichanalai C, Sakanari JA, Park H.

Yonsei Med J. 2004 Feb 29;45(1):129-34.

Supplemental Content

Support Center